Add, upgrade, or consolidate your research technology with zero downtime
Introducing a New Feature to Rapidly Migrate Active Studies and Upgrade Your Trials
THREAD is excited to announce new capabilities designed to migrate studies from legacy systems to modernize their clinical research operations without pause.
Upgrading active clinical trials from legacy technologies has long been a complex challenge—fraught with risks of study team disruption, downtime, and compromised data quality. These new features will enable you to conduct your studies with greater flexibility, efficiency, and precision by seamlessly transitioning to a single configurable platform. Developed in close partnership with our clients and platform users, this innovative feature delivers:
- Rapid transition from legacy platforms in hours, with a complete audit trail
- Seamless participant experience at any study stage to ensure continuity
- Universal data acceptance and processing from any legacy or partner system, regardless of format
- Real-time operation with zero downtime for research sites, participants, and study teams
“Sponsors and CROs are turning to us to migrate from outdated systems, consolidate multiple platforms, and reduce overall clinical trial costs. Our solution offers a fully configurable, no-downtime path forward—built precisely to address the complexities of today’s trials,” said John Reites, Co-founder and CEO at THREAD.
Explore the latest THREAD platform release today.
Learn More About This Latest Release